|
| Status |
Public on Oct 02, 2023 |
| Title |
TMIGD2 is a leukemic stem cell-specific surface marker in human acute myeloid leukemia |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
To comprehensibly understand the genes and pathways associated with TMIGD2 expression in CD34-expressing leukemia cells,
RNA-seq was conducted on FACS-purified CD34+TMIGD2+ and CD34+TMIGD2- subfractions of six primary AML specimens.
|
| |
|
| Overall design |
Comparative gene expression profiling analysis of RNA-seq data for CD34+TMIGD2+ and CD34+TMIGD2- primary AML cells.
|
| |
|
| Contributor(s) |
Hao W, Phillip G, Deyou Z, Xingxing Z |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
Sep 29, 2022 |
| Last update date |
Oct 02, 2023 |
| Contact name |
Hao Wang |
| E-mail(s) |
hao.wang@einsteinmed.edu
|
| Phone |
7184304154
|
| Organization name |
Albert Einstein College of Medicine
|
| Street address |
1300 morris park ave, Forch 405
|
| City |
bronx |
| State/province |
NY |
| ZIP/Postal code |
10461 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
| Samples (12)
|
| GSM6607222 |
AML Pt#8, CD34+TMIGD2 postive [X8_TMpositive_19200R_02_01] |
| GSM6607223 |
AML Pt#8, CD34+TMIGD2 negative [X8_TMnegative_19200R_02_02] |
| GSM6607224 |
AML Pt#24, CD34+TMIGD2 postive [X24_TMpositive_19200R_02_03] |
| GSM6607225 |
AML Pt#24, CD34+TMIGD2 negative [X24_TMnegative_19200R_02_04] |
| GSM6607226 |
AML Pt#31, CD34+TMIGD2 postive [X31_TMpositive_19200R_02_05] |
| GSM6607227 |
AML Pt#31, CD34+TMIGD2 negative [X31_TMnegative_19200R_02_06] |
| GSM6607228 |
AML Pt#36, CD34+TMIGD2 postive [X36_TMpositive_19200R_02_07V1] |
| GSM6607229 |
AML Pt#36, CD34+TMIGD2 negative [X36_TMnegative_19200R_02_08V1] |
| GSM6607230 |
AML Pt#40, CD34+TMIGD2 postive [X40_TMpositive_19200R_02_09] |
| GSM6607231 |
AML Pt#40, CD34+TMIGD2 negative [X40_TMnegative_19200R_02_10] |
| GSM6607232 |
AML Pt#46, CD34+TMIGD2 postive [X46_TMpositive_19200R_02_11] |
| GSM6607233 |
AML Pt#46, CD34+TMIGD2 negative [X46_TMnegative_19200R_02_12] |
|
| Relations |
| BioProject |
PRJNA885507 |
Less...
More...